Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Employment agrmnt
Quarterly results
Director comp.
MoonLake Immunotherapeutics Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Quarterly results
Docs: "MoonLake Immunotherapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update"
06/30/2023 SC 13D/A BIOTECHNOLOGY VALUE FUND L P reports a 35.8% stake in MoonLake Immunotherapeutics
06/29/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "MOONLAKE IMMUNOTHERAPEUTICS"
06/29/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
06/07/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/19/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/11/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/10/2023 EFFECT Form EFFECT - Notice of Effectiveness:
05/05/2023 EFFECT Form EFFECT - Notice of Effectiveness:
05/01/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
05/01/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
04/26/2023 ARS Form ARS - Annual Report to Security Holders:
04/26/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/26/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/19/2023 8-K Quarterly results
03/31/2023 SC 13G Chen Bihua reports a 17.6% stake in MoonLake Immunotherapeutics
03/28/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
03/28/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/20/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/20/2023 10-K Annual Report for the period ended December 31, 2022
03/20/2023 8-K Quarterly results
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
02/14/2023 SC 13G/A PRICE T ROWE ASSOCIATES INC reports a 2.1% stake in MoonLake Immunotherapeutics
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/27/2023 SC 13G/A Merck Healthcare KGaA reports a 7.9% stake in MoonLake Immunotherapeutics
09/30/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/12/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
08/12/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/03/2022 SC 13G Merck Healthcare KGaA reports a 8.3% stake in MoonLake Immunotherapeutics
08/03/2022 EFFECT Form EFFECT - Notice of Effectiveness:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy